LYPLYZE
Dead / Abandoned — Abandoned — no statement of use filed (as of 19 Jun 2023)
What this means for you
This application is over — abandoned 19 Jun 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88680646
- Mark type
- Stylized text
- Filed
- 05 Nov 2019
- Published for opposition
- 24 Mar 2020
- Abandoned
- 19 Jun 2023
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Cardiovascular pharmaceuticals; pharmaceutical preparations for the treatment of hypercholesterolemia
Owner
- NOVARTIS AG, BASEL, CH
- The Medicines Company, Parsippany, NJ, US
- The Medicines Company, Parsippany, NJ, US
Prosecution history
- 20 Jun 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 19 Jun 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 06 Dec 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Dec 2022 — SOU EXTENSION 5 GRANTED
- 20 Nov 2022 — SOU EXTENSION 5 FILED
- 01 Dec 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 20 Nov 2022 — SOU TEAS EXTENSION RECEIVED
- 05 Jul 2022 — ASSIGNED TO EXAMINER
- 12 May 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 May 2022 — SOU EXTENSION 4 GRANTED
- 10 May 2022 — SOU EXTENSION 4 FILED
- 10 May 2022 — SOU TEAS EXTENSION RECEIVED
- 01 Dec 2021 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 18 Nov 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Nov 2021 — SOU EXTENSION 3 GRANTED